Dendritic cells (DCs) are hematopoietic cells that initiate immune response
s by presenting antigen to T cells. Granulocyte-macrophage colony-stimulati
ng factor (GM-CSF) is a primary growth factor for DCs in vitro, but recentl
y it was recognized that other factors including flt3 ligand (FL) and G-CSF
expand various DC subsets in vivo. DCs undergo a complex series of maturat
ion and activation steps after they acquire antigen and before they can act
ivate resting T cells, In addition, they must traffic to T-cell-rich areas
of lymph nodes (LN) to achieve this. Each of these steps is tightly regulat
ed, and in the last year progress has been made in identifying some of the
key molecules involved in each of these steps. This progress will further t
he efforts underway to develop DCs as vaccine adjuvants. (C) 2001 Lippincot
t Williams & Wilkins. Inc.